IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v449y2007i7159d10.1038_449180a.html
   My bibliography  Save this article

The road to recovery

Author

Listed:
  • Carlos M. Morel

    (Carlos M. Morel is director of the Centre for Technological Development in Health, Fiocruz, Rio de Janeiro, Brazil.)

  • José R. Carvalheiro

    (José R. Carvalheiro is vice-president for research and development at Fiocruz.)

  • Carmen N. P. Romero

    (Carmen N. P. Romero is a science and technology analyst on the Innovation Project at Fiocruz.)

  • Eduardo A. Costa

    (Eduardo A. Costa is director of the Medicines and Drugs Technology Institute, Fiocruz.)

  • Paulo M. Buss

    (Paulo M. Buss is the president of Fiocruz.)

Abstract

Brazil urgently needs to improve infrastructure for generating pharmaceuticals to alleviate the plight of its poor and marginalized populations, say Carlos M. Morel et al.

Suggested Citation

  • Carlos M. Morel & José R. Carvalheiro & Carmen N. P. Romero & Eduardo A. Costa & Paulo M. Buss, 2007. "The road to recovery," Nature, Nature, vol. 449(7159), pages 180-182, September.
  • Handle: RePEc:nat:nature:v:449:y:2007:i:7159:d:10.1038_449180a
    DOI: 10.1038/449180a
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/449180a
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/449180a?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ricardo B. Sampaio & Bruna P. F. Fonseca & Ashwin Bahulkar & Boleslaw K. Szymanski, 2017. "Network analysis to support public health: evolution of collaboration among leishmaniasis researchers," Scientometrics, Springer;Akadémiai Kiadó, vol. 111(3), pages 2001-2021, June.
    2. Alexandre Guimarães Vasconcellos & Carlos Medicis Morel, 2012. "Enabling Policy Planning and Innovation Management through Patent Information and Co-Authorship Network Analyses: A Study of Tuberculosis in Brazil," PLOS ONE, Public Library of Science, vol. 7(10), pages 1-10, October.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:449:y:2007:i:7159:d:10.1038_449180a. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.